PELLETIER SAUNDRA L 4
4 · Evofem Biosciences, Inc. · Filed Sep 10, 2020
Insider Transaction Report
Form 4
PELLETIER SAUNDRA L
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2020-09-08$3.26/sh−122,500$399,350→ 360,888 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.09 to $3.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- [F2]The total amount of securities beneficially owned includes 4,303 shares of common stock the reporting person purchased in accordance with the 2019 ESPP based on 85% of the closing stock price on June 12,2020, the last trading day of the purchase period.